Foreign Filer Report • Oct 2, 2023
Foreign Filer Report
Open in ViewerOpens in native device viewer
For the month of October, 2023
Commission file number: 001-41491
(Translation of registrant's name into English)
Arik Einstein Street, Bldg. B, 1st Floor Herzliya 4659071, Israel (Address of principal executive offices) _____________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Nayax Ltd. (the "Company") hereby files its Unaudited Condensed Consolidated Interim Financial Statements as of June 30, 2023.
This Form 6-K and Exhibit 99.1 are hereby incorporated by reference into all effective registration statements filed by the Company with the U.S. Securities and Exchange Commission (the "SEC") or with the Israel Securities Authority, including without limitation the Company's Registration Statement on Form S-8 filed with the SEC (File No. 333-267542).
The following exhibits are furnished as part of this Form 6-K:
101 The following financial information from Nayax Ltd.'s, formatted in inline XBRL (eXtensible Business Reporting Language): (i) Unaudited interim condensed consolidated statements of financial position as of June 30, 2023 (ii) Unaudited interim condensed consolidated statements of comprehensive loss as for the Six months ended on June 30, 2023; (iii) Unaudited interim condensed consolidated statements of loss as for the Six months ended on June 30, 2023; (iv) Unaudited condensed consolidated statements of cash flow for the six and three months ended on June 30, 2023; and (v) Notes to the unaudited consolidated financial statements.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
By: /s/ Gal Omer
Name: Gal Omer Title: Chief Legal Officer
Date: October 2, 2023
Exhibit 99.1
NAYAX LTD. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS As of June 30, 2023 (Unaudited)
TABLE OF CONTENTS
| Page | |
|---|---|
| CONDENSED CONSOLIDATED FINANCIAL STATEMENTS: | |
| Condensed consolidated statements of financial position | F - 3-F - 4 |
| Condensed consolidated statements of loss | F - 5 |
| Condensed consolidated statements of comprehensive loss | F - 6 |
| Condensed consolidated statements of changes in shareholders' equity | F - 7-F - 8 |
| Condensed consolidated statements of cash flows | F - 9-F - 10 |
| Notes to the condensed consolidated financial statements | F - 11-F - 15 |
| June 30 | December 31 2022 |
||
|---|---|---|---|
| 2023 | |||
| U.S. dollars in thousands | |||
| ASSETS | |||
| CURRENT ASSETS: | |||
| Cash and cash equivalents | 31,050 | 33,880 | |
| Restricted cash transferable to customers for processing activity | 50,575 | 34,119 | |
| Short-term bank deposits | 1,234 | 83 | |
| Receivables in respect of processing activity | 32,404 | 25,382 | |
| Trade receivable, net | 32,462 | 27,412 | |
| Inventory | 22,924 | 23,807 | |
| Other current assets | 7,215 | 5,777 | |
| Total current assets | 177,864 | 150,460 | |
| NON-CURRENT ASSETS: | |||
| Long-term bank deposits | 1,315 | 1,336 | |
| Other long-term assets | 5,196 | 2,948 | |
| Investment in associates | 5,837 | 6,579 | |
| Right-of-use assets, net | 6,340 | 7,381 | |
| Property and equipment, net | 5,930 | 6,668 | |
| Goodwill and intangible assets, net | 59,344 | 55,116 | |
| Total non-current assets | 83,962 | 80,028 | |
| TOTALASSETS | 261,826 | 230,488 |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
| June 30 | December 31 | ||
|---|---|---|---|
| 2023 | 2022 | ||
| U.S. dollars in thousands | |||
| LIABILITIES AND EQUITY | |||
| CURRENT LIABILITIES: | |||
| Short-term bank credit | 18,069 | 7,684 | |
| Current maturities of long-term bank loans | 1,033 | 1,052 | |
| Current maturities of loans from others and other long-term liabilities | 4,990 | 4,126 | |
| Current maturities of leases liabilities | 2,216 | 2,206 | |
| Payables in respect of processing activity | 94,846 | 63,336 | |
| Trade payables | 12,135 | 14,574 | |
| Other payables | 17,936 | 17,229 | |
| Total current liabilities | 151,225 | 110,207 | |
| NON-CURRENT LIABILITIES: | |||
| Long-term bank loans | 861 | 1,444 | |
| Long-term loans from others and other long-term liabilities | 3,606 | 7,062 | |
| Post-employment benefit obligations, net | 429 | 403 | |
| Lease liabilities | 5,058 | 5,944 | |
| Deferred income taxes | 691 | 793 | |
| Total non-current liabilities | 10,645 | 15,646 | |
| TOTAL LIABILITIES | 161,870 | 125,853 | |
| EQUITY: | |||
| Share capital | 8 | 8 | |
| Additional paid in capital | 152,648 | 151,406 | |
| Capital reserves | 9,880 | 9,771 | |
| Accumulated deficit | (62,580) | (56,550) | |
| TOTAL EQUITY | 99,956 | 104,635 | |
| TOTAL LIABILITIES AND EQUITY | 261,826 | 230,488 |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
| Six months ended June 30 |
Three months ended June 30 |
||||
|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | ||
| U.S. dollars in thousands | |||||
| Notes | (Excluding loss per share data) | ||||
| Revenues | 4 | 108,569 | 75,343 | 56,159 | 41,211 |
| Cost of revenues | 5 | (69,838) | (48,144) | (35,303) | (27,105) |
| Gross Profit | 38,731 | 27,199 | 20,856 | 14,106 | |
| Research and development expenses | (10,106) | (10,692) | (4,970) | (5,098) | |
| Selling, general and administrative expenses | (33,967) | (29,946) | (17,536) | (15,121) | |
| Depreciation and amortization in respect of technology and capitalized development costs | (2,814) | (2,111) | (1,674) | (1,066) | |
| Other expenses | - | (866) | - | (866) | |
| Share of loss of equity method investees | (741) | (1,071) | (383) | (570) | |
| Operating loss | (8,897) | (17,487) | (3,707) | (8,615) | |
| Finance expenses | (118) | (2,357) | (40) | (1,499) | |
| Loss before taxes on income | (9,015) | (19,844) | (3,747) | (10,114) | |
| Income tax expense | (485) | (285) | (226) | (235) | |
| Loss for the period | (9,500) | (20,129) | (3,973) | (10,349) | |
| Loss per share of the Company: | |||||
| Basic and diluted loss per share | (0.288) | (0.614) | (0.120) | (0.316) |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
| Six months ended June 30 |
Three months ended June 30 |
||||
|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | ||
| U.S. dollars in thousands | |||||
| Loss for the period | (9,500) | (20,129) | (3,973) | (10,349) | |
| Other comprehensive loss for the period: | |||||
| Items that may be reclassified to profit or loss: | |||||
| Exchange differences on translation of foreign operations | 109 | (489) | 70 | (339) | |
| Total comprehensive loss for the period | (9,391) | (20,618) | (3,903) | (10,688) | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
| Share capital |
Additional paid in capital |
Remeasurement of post-employment benefit obligations |
Other capital reserves |
Foreign currency translation reserve |
Accumulated deficit |
Total equity |
|
|---|---|---|---|---|---|---|---|
| U.S. dollars in thousands | |||||||
| Balance at January 1, 2023 | 8 | 151,406 | 248 | 9,503 | 20 | (56,550) | 104,635 |
| Changes in the six months ended June 30, 2023: | |||||||
| Loss for the period | - | - | - | - | - | (9,500) | (9,500) |
| Other comprehensive income for the period | - | - | - | - | 109 | - | 109 |
| Employee options exercised | * | 1,242 | - | - | - | - | 1,242 |
| Share-based payment | - | - | - | - | - | 3,470 | 3,470 |
| Balance on June 30, 2023 | 8 | 152,648 | 248 | 9,503 | 129 | (62,580) | 99,956 |
| Balance at January 1, 2022 | 8 | 150,366 | 102 | 9,503 | 394 | (28,697) | 131,676 |
| Changes in the six months ended June 30, 2022: | |||||||
| Loss for the period | - | - | - | - | - | (20,129) | (20,129) |
| Other comprehensive loss for the period | - | - | - | - | (489) | - | (489) |
| Employee options exercised | * | 397 | - | - | - | - | 397 |
| Share-based payment | - | - | - | - | - | 5,635 | 5,635 |
| Balance on June 30, 2022 | 8 | 150,763 | 102 | 9,503 | (95) | (43,191) | 117,090 |
(*) Represents an amount lower than \$1 thousand.
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
| Share capital |
Additional paid in capital |
Remeasurement of post-employment benefit obligations |
Other capital reserves |
Foreign currency translation reserve |
Accumulated deficit |
Total equity |
|
|---|---|---|---|---|---|---|---|
| U.S. dollars in thousands | |||||||
| Balance at April 1, 2023 | 8 | 151,710 | 248 | 9,503 | 59 | (60,286) | 101,242 |
| Changes in the three months ended June 30, 2023: | |||||||
| Loss for the period | - | - | - | - | - | (3,973) | (3,973) |
| Other comprehensive income for the period | - | - | - | - | 70 | - | 70 |
| Employee options exercised | * | 938 | - | - | - | - | 938 |
| Share-based compensation | - | - | - | - | - | 1,679 | 1,679 |
| Balance on June 30, 2023 | 8 | 152,648 | 248 | 9,503 | 129 | (62,580) | 99,956 |
| Balance at April 1, 2022 | 8 | 150,460 | 102 | 9,503 | 244 | (35,217) | 125,100 |
| Changes in the three months ended June 30, 2022: | |||||||
| Loss for the period | - | - | - | - | - | (10,349) | (10,349) |
| Other comprehensive loss for the period | - | - | - | - | (339) | - | (339) |
| Employee options exercised | * | 303 | - | - | - | - | 303 |
| Share-based compensation | - | - | - | - | - | 2,375 | 2,375 |
| Balance on June 30, 2022 | 8 | 150,763 | 102 | 9,503 | (95) | (43,191) | 117,090 |
(*) Represents an amount lower than \$1 thousand.
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
| Six months ended June 30 |
Three months ended June 30 |
|||
|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | |
| U.S. dollars in thousands | ||||
| CASH FLOWS FROM OPERATING ACTIVITIES: |
||||
| Net loss for the period | (9,500) | (20,129) | (3,973) | (10,349) |
| Adjustments to reconcile net loss to net cash provided by (used in) operations (see Appendix A) | 8,722 | 1,942 | 2,310 | (4,892) |
| Net cash used in operating activities | (778) | (18,187) | (1,663) | (15,241) |
| CASH FLOWS FROM INVESTING ACTIVITIES: |
||||
| Capitalized development costs | (7,984) | (6,131) | (4,449) | (3,269) |
| Acquisition of property and equipment | (274) | (599) | (178) | (410) |
| Loans granted to an equity method investee | (620) | - | (620) | - |
| Increase in bank deposits | (1,182) | (7,048) | (1,123) | (370) |
| Payments for acquisitions of subsidiaries, net of cash acquired | - | 440 | - | 440 |
| Interest received | 448 | 35 | 424 | 35 |
| Investments in financial assets | (97) | (6,686) | (97) | (1,014) |
| Proceeds from sub-lessee | 69 | - | 69 | - |
| Net cash used in investing activities | (9,640) | (19,989) | (5,974) | (4,588) |
| CASH FLOWS FROM FINANCING ACTIVITIES: |
||||
| Interest paid | (1,020) | (261) | (745) | (120) |
| Changes in short-term bank credit | 10,874 | - | 6,643 | - |
| Royalties paid in respect to government assistance plans | (67) | (36) | (67) | (36) |
| Transactions with non-controlling interests | - | (186) | - | - |
| Repayment of long-term bank loans | (502) | (1,711) | (248) | (248) |
| Repayment of long-term loans from others | (2,261) | (1,568) | (1,055) | (626) |
| Repayment of other long-term liabilities | (136) | (148) | (67) | (73) |
| Employee options exercised | 1,033 | 501 | 937 | 410 |
| Principal lease payments | (1,063) | (656) | (489) | (205) |
| Net cash provided by (used in) financing activities | 6,858 | (4,065) | 4,909 | (898) |
| Decrease in cash and cash equivalents | (3,560) | (42,241) | (2,728) | (20,727) |
| Balance of cash and cash equivalents at beginning of period | 33,880 | 87,332 | 33,212 | 64,752 |
| Gains (losses) from exchange differences on cash and cash equivalents | 537 | (3,897) | 424 | (2,618) |
| Gains (losses) from translation differences on cash and cash equivalents of foreign activity operations | 193 | 568 | 142 | 355 |
| Balance of cash and cash equivalents at end of period | 31,050 | 41,762 | 31,050 | 41,762 |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
| Six months ended June 30 |
Three months ended June 30 |
||||
|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | ||
| U.S. dollars in thousands | |||||
| Appendix A – adjustments to reconcile net loss to net cash provided by operations: | |||||
| Adjustments in respect of: | |||||
| Depreciation and amortization | 5,783 | 3,936 | 3,156 | 1,932 | |
| Post-employment benefit obligations, net | 26 | (42) | 22 | (19) | |
| Deferred taxes | (72) | (107) | (36) | (53) | |
| Finance expenses (income), net | (1,018) | 2,988 | (807) | 2,034 | |
| Expenses in respect of long-term employee benefits | 98 | 91 | 38 | 41 | |
| Share of loss of equity method investees | 741 | 1,071 | 383 | 570 | |
| Long-term deferred income | (52) | (52) | (26) | (26) | |
| Expenses in respect of share-based compensation | 2,985 | 5,165 | 1,425 | 2,063 | |
| Total adjustments | 8,491 | 13,050 | 4,155 | 6,542 | |
| Changes in operating asset and liability items: | |||||
| Decrease (Increase) in restricted cash transferable to customers for processing activity | (16,456) | (9,021) | (6,493) | 338 | |
| Increase in receivables from processing activity | (7,023) | (7,965) | (4,662) | (2,777) | |
| Increase in trade receivables | (4,949) | (5,851) | (2,517) | (4,784) | |
| Increase in other current assets | (238) | (7,063) | (1,237) | (7,326) | |
| Decrease (Increase) in inventory | 850 | (10,208) | 4,432 | (7,960) | |
| Increase in payables in respect of processing activity | 31,510 | 15,645 | 15,095 | 609 | |
| Increase (Decrease) in trade payables | (2,032) | 12,106 | (4,516) | 11,160 | |
| Increase (Decrease) in other payables | (1,431) | 1,249 | (1,947) | (694) | |
| Total changes in operating asset and liability items | 231 | (11,108) | (1,845) | (11,434) | |
| Total adjustments to reconcile net loss to net cash provided by (used in) operations | 8,722 | 1,942 | 2,310 | (4,892) | |
| Appendix B – Information regarding investing and financing activities not involving cash flows: | |||||
| Purchase of property and equipment in credit | 2 | 70 | 2 | 70 | |
| Acquisition of right-of-use assets through lease liabilities | 338 | 380 | 243 | 0 | |
| Share based payments costs attributed to development activities, capitalized as intangible assets | 485 | 470 | 254 | 312 | |
| Recognition of receivable balance in respect of sub-lease against derecognition of right-of-use asset in respect of lease of buildings |
455 | - | 455 | - |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
a. Nayax Ltd. (hereafter – the "Company") was incorporated in January 2005. The Company provides processing and software as a service (SaaS) business operations solutions and services via a global platform. The Company is marketing its POS devices and SaaS solutions it developed in more than 60 countries worldwide (including Israel) through subsidiaries (the Company and the subsidiaries, hereafter – the "Group") and through local distributors.
The Company is a public entity and its shares are being traded on the Tel Aviv Stock Exchange (TASE) since May 2021. On September 21, 2022, Company's Ordinary Shares were listed on the Nasdaq Global Select Market under the symbol NYAX. As of that date, the Company is dual listed on Nasdaq and the TASE.
b. These condensed consolidated interim financial statements were approved by the Board of Directors on September 27, 2023, and should be read in conjunction with the Company's Annual Report on Form 20-F for the fiscal year ended December 31, 2022 (the "2022 Annual Report") filed with the Securities and Exchange Commission (the "SEC") on March 1, 2023.
a. The unaudited condensed consolidated interim consolidated financial statements of the Company as of June 30, 2023, and for the six-months and three-months interim periods ended on that date (hereinafter: "the Condensed Interim Financial Information") have been prepared in accordance with International Accounting Standard IAS 34, "Interim Financial Reporting". These Condensed Consolidated Interim Financial Statements, that are unaudited, do not include all the information and disclosures that would otherwise be required in a complete set of annual financial statements and should be read in conjunction with the annual financial statements as of December 31, 2022, and their accompanying notes, which have been prepared in accordance with International Financial Reporting Standards ("IFRS") as published by the International Accounting Standards Board ("IASB"). The results of the Group and in the six -months and three-months periods ended June 30, 2023, do not necessarily provide indication of the results that can be expected in the year ended December 31, 2023.
The preparation of Condensed Interim Financial Information requires management to exercise its judgment and to use significant accounting estimates and assumptions that affect the application of the Group's accounting policy and the amounts of reported assets, liabilities, income and expenses. Actual results may materially differ from those estimates. In preparation of these Condensed Interim Financial Information, the significant accounting judgment exercised by management in implementing the accounting policy of the Group and the uncertainty associated with key sources of estimates are identical to those in the consolidated annual financial statements for the year ended December 31, 2022.
Significant accounting policies and calculation methods that have been applied in the preparation of the Condensed Interim Financial Information are consistent with those used in the preparation of the Group's 2022 annual Consolidated Financial Statements.

| Six months ended June 30 |
Three months ended June 30 |
|||
|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | |
| U.S. dollars in thousands | ||||
| Revenues from sale of integrated POS devices | 39,952 | 27,394 | 19,833 | 15,777 |
| Recurring revenues: | ||||
| SaaS revenues | 27,473 | 21,172 | 14,284 | 10,825 |
| Payment processing fee | 41,144 | 26,777 | 22,042 | 14,609 |
| 68,617 | 47,949 | 36,326 | 25,434 | |
| Total | 108,569 | 75,343 | 56,159 | 41,211 |
| Six months ended June 30 |
Three months ended June 30 |
|||
|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | |
| U.S. dollars in thousands | ||||
| Cost of integrated POS devices sales | 33,913 | 25,516 | 16,138 | 14,674 |
| Cost of recurring revenues | 35,925 | 22,628 | 19,165 | 12,431 |
| Total | 69,838 | 48,144 | 35,303 | 27,105 |
a. As of December 31, 2022, the Company had a short-term credit facility in the amount of NIS 35 million (\$10.6 million) from an Israeli bank that bears a prime based variable interest rate. In April 2023, the short-term credit facility was increased to NIS 42.5 million (\$11.5 million).
b. In May 2023, the Company received a short-term credit facility in the amount of NIS 17 million (\$4.6 million) from an Israeli bank that bears a prime based variable interest rate.
c. Under the two above financing agreements, the Company is required to meet certain financial covenants. As of June 30, 2023, the Company met all the covenants.
On January 31, 2023, the Company entered into a binding agreement for the purchase of the entire share capital (hereinafter "Purchased Shares") of Roseman Engineering Ltd. and Roseman Holdings Ltd. (hereinafter, together, "Roseman"). Roseman are private entities founded under the law of the State of Israel that manage smart systems in the fields of refueling, charging stations and management system for vehicle fleets. In consideration of the transaction, the Company will pay to Roseman NIS 15,000 thousand (the "Purchase Price"). The agreement is subject to certain closing conditions and as of the date of these financial statements, the purchase is pending the approval of the Israeli Competition Authority (hereinafter the "ICA").

During the six months ended June 30, 2023, the Company filed with the Israel Securities Authority (hereinafter "ISA") a shelf prospectus (the "Shelf Prospectus"). The Shelf Prospectus allows the Company to raise from time to time funds through the offering and sale of various securities including debt and equity, in Israel, at the discretion of the Company.
On August 23, 2023, the Shelf Prospectus was approved in principle by the ISA. The Shelf Prospectus will be effective for a period of one year from the date of the approval, subject to potential extensions. The Company has not yet made any decision as to any offering of any securities, nor as to the scope, terms or timing of any offering, and there is no certainty that any such offering will be made.
On June 21, 2023, a new agreement of collaboration (hereinafter "New Agreement") was signed between the Company, Bank Hapoalim (hereinafter "BHP"), Mr. Alon Feit (hereinafter "Feit"), IoT Capital Ltd. (hereinafter "IoT Capital"), and IoT Technology Holdings Ltd., a new Israeli company (hereinafter "IoT Technology" or the "Receiving Company", all together the "Collaborators" or the "Parties"). The New Agreement replaces an older agreement (hereinafter "the Old Agreement") signed on June 9, 2022 between the Parties which was signed to establish and operate an innovative international platform, which shall provide financing options mainly for small and medium businesses for acquiring POS devices, automated vending machines and electric vehicle charging stations. Under the terms of the Old Agreement, the Parties shall incorporate IoT Technology with an initial holding structure according to which 49.1% of IOT's share capital shall be held by the Company, 30.9% by Feit, and 20% by Bank Hapoalim. For further information on the Old Agreement, please refer to Note 6(g) in the 20- F for the year ended December 31, 2022 as published on March 1, 2023.
Under the terms of the New Agreement, the initial holding structure remained unchanged as determined by the Old Agreement. The New Agreement also sets the same amounts as determined by the Old Agreement where the Company shall invest in the Receiving Company an amount of \$1.5 million, Feit shall invest an amount of \$0.5 million, and Bank Hapoalim shall invest an amount of \$1.5 million and provide an additional loan of \$1.5 million. Similar to the Old Agreement, the New Agreement also includes three options, where;
The investment in IoT Technology shares is treated under the equity method as required by IAS 28 "Investments in Associates and Joint Ventures".
The following table presents the balances related to the investment in IoT Technology as of the date of the New Agreement:
| U.S. Dollars in | |
|---|---|
| thousands | |
| Financial assets at fair value through profit or loss (*) | 1,918 |
| Liability for deferred consideration | 1,500 |
| Deferred income (**) | 418 |
(*) The options mentioned above are measured at fair value through profit and loss. As of June 30, 2023, there has been no impact through profit on the Company's profit and loss report.
(**) Deferred income represents an advance for providing future services by the Company to IoT Technology.
During the six months ended June 30, 2023, the ICA has requested from Nayax certain documents and other information related mainly to its acquisition of On Track Innovation Ltd. The Company has provided the requested information and commenced discussions with the ICA, which are ongoing.
The carrying amounts of all financial assets and financial liabilities in the Company's statement of financial position reasonably approximate their fair value.
Loss per share is calculated by dividing the loss attributable to equity holders of the Company by the weighted average number of ordinary shares in issue (in thousands excluding loss per share data):
| Six months ended | Three months ended | |||||
|---|---|---|---|---|---|---|
| June 30 | June 30 | |||||
| 2023 | 2022 | 2023 | 2022 | |||
| Loss for the period | (9,500) | (20,129) | (3,973) | (10,349) | ||
| Weighted average of number of ordinary shares | 33,023 | 32,781 | 33,075 | 32,805 | ||
| Basic loss per ordinary share | (0.288) | (0.614) | (0.120) | (0.316) |
Instruments that can potentially dilute basic earnings per share in the future, but were not included in the calculation of diluted earnings per share, as their impact was anti-dilutive (thousands of shares):
| June 30, 2023 | June 30, 2022 | |
|---|---|---|
| Options and unvested RSU issued as part of share-based payment | 3,737 | 3,893 |
| Risk-free interest | Average standard | |||||
|---|---|---|---|---|---|---|
| Allotment date | Share price | Exercise price | Expected term | rate | deviation | Fair value |
| June 26, 2023 – Options | \$ 19.34 |
\$ 18.83 |
5 | 3.96% | 67.8% \$ | 11.03 |
| June 26, 2023 – RSUs | \$ 19.34 |
- | - | - | - | \$ 19.34 |
On June 26, 2023, the Company allotted 27,500 options and 137,524 restricted share units (RSUs) to employees of the Company and subsidiaries. The vesting period of the options and RSUs is 4 years, with 25% of the options vest on the first anniversary of grant date, and after that, additional 6.25% of the options vest on the last day of each subsequent calendar quarter. Options not exercised within 5 years of inception date will expire.
In respect of employees and officers in Israel, all plans described above are supposed to be managed under the rules of the capital option, as set out in Section 102 of the Income Tax Ordinance. The allotments to Israelis who are not employees are subject to Section 3(i) to the Income Tax Ordinance. Overseas employees and service providers are subject to tax laws in their respective countries.
In July 2023, the Company received a short-term credit facility from an Israeli bank in the amount of \$9,750 thousand. The short-term credit facility bears a prime based variable interest rate.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.